The Translational Medicine Research Collaboration, the unique venture bringing together one of the world's biggest pharmaceutical companies, Wyeth, with Scotland's medical research centers, has announced the first round of research projects to be funded through a new L50.0 million ($96.7 million) initiative.
Almost L8.0 million of funding has been released to support 28 new research projects covering a wide range of therapeutic areas including cardiovascular and metabolic disease, the central nervous system, oncology, inflammation and women's health.
The projects will commence imminently across Scotland and, as a result, over 40 new jobs have already been created in the universities while a further 50 new jobs are projected for the Core Laboratory which will be located in Dundee.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze